Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Open-market sale Director sold 100 shares at $110.59 ($11,059)
  2. 4 Open-market sale Director sold 100 shares at an average $101.15 ($10,115)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 800 shares (to pay taxes)
  4. 4 Open-market sale Director sold 100 shares at an average $107.77 ($10,777)
  5. 4 Open-market sale Director sold 100 shares at $102.60 ($10,260)
  6. 4 Option exercise Senior V.P. Protein Platforms acquired 1,667 shares (option exercise)
  7. 4 Open-market sale Director sold 100 shares at $103.57 ($10,357)
  8. 4 Open-market sale Director sold 100 shares at $108.92 ($10,892)
  9. 4 Open-market sale Director sold 1,000 shares at $106.73 ($106,733)
  10. 4 Open-market sale Director sold 100 shares at $105.75 ($10,575)
  11. 4 Open-market sale Director sold 100 shares at $104.71 ($10,471)
  12. 4 Grant or award Director acquired 914 shares (grant or award)
  13. 4 Grant or award Director acquired 914 shares (grant or award)
  14. 4 Grant or award Director acquired 914 shares (grant or award)
  15. 4 Grant or award Director acquired 914 shares (grant or award)
  16. 4 Grant or award Director acquired 914 shares (grant or award)
  17. 4 Grant or award Director acquired 914 shares (grant or award)
  18. 4 Grant or award Director acquired 914 shares (grant or award)
  19. 4 Open-market sale Director sold 100 shares at $108.91 ($10,891)
  20. 4 Open-market sale SVP Clinical Controls sold 524 shares at $110.50 ($57,904)

Page 19 of 35 · 695 filings